OTC Markets OTCQB - Delayed Quote USD

PetVivo Holdings, Inc. (PETV)

Compare
0.4700 +0.0025 (+0.53%)
At close: 3:54 PM EDT
Loading Chart for PETV
DELL
  • Previous Close 0.4675
  • Open 0.4700
  • Bid 0.4110 x --
  • Ask 0.4600 x --
  • Day's Range 0.4600 - 0.4700
  • 52 Week Range 0.2900 - 2.1900
  • Volume 27,362
  • Avg. Volume 22,817
  • Market Cap (intraday) 9.402M
  • Beta (5Y Monthly) 2.55
  • PE Ratio (TTM) --
  • EPS (TTM) -0.6400
  • Earnings Date Nov 12, 2024 - Nov 18, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minnesota.

www.petvivo.com

20

Full Time Employees

March 31

Fiscal Year Ends

Recent News: PETV

View More

Performance Overview: PETV

Trailing total returns as of 9/27/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

PETV
55.66%
S&P 500
20.30%

1-Year Return

PETV
73.60%
S&P 500
34.27%

3-Year Return

PETV
84.98%
S&P 500
28.79%

5-Year Return

PETV
70.38%
S&P 500
92.71%

Compare To: PETV

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PETV

View More

Valuation Measures

Annual
As of 9/26/2024
  • Market Cap

    9.00M

  • Enterprise Value

    10.16M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.26

  • Price/Book (mrq)

    10.85

  • Enterprise Value/Revenue

    10.41

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -203.99%

  • Return on Equity (ttm)

    -1,646.73%

  • Revenue (ttm)

    975.27k

  • Net Income Avi to Common (ttm)

    -10.11M

  • Diluted EPS (ttm)

    -0.6400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    12.41k

  • Total Debt/Equity (mrq)

    140.65%

  • Levered Free Cash Flow (ttm)

    -3.86M

Research Analysis: PETV

View More

Company Insights: PETV

Research Reports: PETV

View More

People Also Watch